Triethylamine (Casrn 121-44-8) Administered by Inhalation to F344/N Rats and B6c3f1/N Mice

Triethylamine (Casrn 121-44-8) Administered by Inhalation to F344/N Rats and B6c3f1/N Mice

NTP TECHNICAL REPORT ON THE OXICITY TUDIES OF T S TRIETHYLAMINE (CASRN 121-44-8) ADMINISTERED BY INHALATION TO F344/N RATS AND B6C3F1/N MICE NTP TOX 78 MARCH 2018 NTP Technical Report on the Toxicity Studies of Triethylamine (CASRN 121-44-8) Administered by Inhalation to F344/N Rats and B6C3F1/N Mice Toxicity Report 78 March 2018 National Toxicology Program Public Health Service U.S. Department of Health and Human Services ISSN: 2378-8992 Research Triangle Park, North Carolina, USA NOT FOR Review Draft Triethylamine, NTP TOX 78 Foreword The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Toxicity Study Report series began in 1991. The studies described in the Toxicity Study Report series are designed and conducted to characterize and evaluate the toxicologic potential of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. The interpretive conclusions presented in the Toxicity Study Reports are based only on the results of these NTP studies. Extrapolation of these results to other species, including characterization of hazards and risks to humans, requires analyses beyond the intent of these reports. Selection per se is not an indicator of a substance’s toxic potential. The NTP conducts its studies in compliance with its laboratory health and safety guidelines and FDA Good Laboratory Practice Regulations and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use are in accordance with the Public Health Service Policy on Humane Care and Use of Animals. Studies are subjected to retrospective quality assurance audits before being presented for public review. NTP Toxicity Study Reports are indexed in the National Center for Biotechnology Information (NCBI) Bookshelf database and are available free of charge electronically on the NTP website (http://ntp.niehs.nih.gov). Additional information regarding this study may be requested through Central Data Management (CDM) at [email protected]. Toxicity data are available through NTP’s Chemical Effects in Biological Systems (CEBS) database: https://www.niehs.nih.gov/research/resources/database/cebs/index.cfm. ii Triethylamine, NTP TOX 78 Table of Contents Foreword ......................................................................................................................................... ii Tables ............................................................................................................................................. iv Figures............................................................................................................................................. v About This Report.......................................................................................................................... vi Peer Review ................................................................................................................................... ix Publication Details ...........................................................................................................................x Abstract .......................................................................................................................................... xi Introduction ......................................................................................................................................1 Chemical and Physical Properties ...............................................................................................1 Production, Use, and Human Exposure ......................................................................................1 Regulatory Status ........................................................................................................................2 Absorption, Distribution, Metabolism, Excretion, and Toxicokinetics ......................................2 Toxicity .......................................................................................................................................3 Experimental Animals .........................................................................................................3 Humans ................................................................................................................................4 Carcinogenicity ...........................................................................................................................4 Genetic Toxicity ..........................................................................................................................5 Study Rationale ...........................................................................................................................5 Materials and Methods .....................................................................................................................6 Procurement and Characterization of Triethylamine ..................................................................6 Vapor Generation and Exposure System ....................................................................................6 Vapor Concentration Monitoring ................................................................................................7 Chamber Atmosphere Characterization ......................................................................................7 Animal Welfare ...........................................................................................................................8 Two-week Studies .......................................................................................................................8 Three-month Studies ...................................................................................................................9 Statistical Methods ....................................................................................................................14 Calculation and Analysis of Lesion Incidences .................................................................14 Analysis of Continuous Variables .....................................................................................14 Quality Assurance Methods ......................................................................................................15 Genetic Toxicology ...................................................................................................................15 Bacterial Mutagenicity Test Protocol ................................................................................15 Mouse Peripheral Blood Micronucleus Test Protocol .......................................................15 Evaluation Protocol ............................................................................................................16 Results ............................................................................................................................................17 Rats ............................................................................................................................................17 Two-week Study ................................................................................................................17 Three-month Study ............................................................................................................21 Mice...........................................................................................................................................27 Two-week Study ................................................................................................................27 iii Triethylamine, NTP TOX 78 Three-month Study ............................................................................................................30 Genetic Toxicology ...................................................................................................................35 Discussion ......................................................................................................................................38 References ......................................................................................................................................42 Appendix A. Summary of Nonneoplastic Lesions in Rats and Mice ......................................... A-1 Appendix B. Genetic Toxicology ................................................................................................B-1 Appendix C. Clinical Pathology Results .....................................................................................C-1 Appendix

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    124 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us